Gaudium IVF & Women Health Ltd: GMP, Profit, Price & expert review

Last updated on February 27th, 2026 at 08:19 am

Gaudium IVF & Women Health Limited is a healthcare company specialising in fertility treatments and women’s reproductive health services, including In Vitro Fertilisation (IVF), ICSI, IUI, and comprehensive gynaecological care delivered through a network of centres across India – a business aimed at facilitating assisted conception and related medical support for patients.

It operates a network of approximately 36 state‑of‑the‑art centres across six Indian states, serving thousands of patients domestically and internationally, and holds significant brand recognition in the IVF sector.

Gaudium IVF & Women Health Limited has filed DRHP with SEBI for a proposed IPO with an issue size of total ~2.08 Cr equity shares consisting Fresh Issue of ~1.14 Cr equity shares and Offer for Sale (OFS) of ~0.94 Cr equity shares.

Subscription date to apply for the IPO starts from 20th Feb’26 & closes on 26-Feb’26. Price band for the IPO is ₹ 75-79 with a lot size of 189 shares.

Issue Size:2.08 Cr equity shares
Fresh Issue:1.14 Cr equity shares
Offer for Sale:0.94 Cr equity shares
Price Range:₹ 75-79
Lot Size:189
GMP₹ 0

Gaudium IVF & Women Health Limited important data points


Revenue, PAT, EBITDA

YearFiscal 2025
Networth₹ 46.3 Cr
Revenue:₹ 70.7 Cr
EBITDA₹ 28.6 Cr
PAT₹ 19.1 Cr
EBITDA Margin:~40.48%
PAT Margin~26.96%
Face Value:Rs. 05 per Equity Share

IPO important dates

Open Date:20-Feb
Close Date:24-Feb
Anchor Investor Bidding19-Feb
Allotment Date:25-Feb
Refunds & Demat Credit26-Feb
Tentative Listing Date:27-Feb

Use of Proceeds

PurposeAmount
Establishing New IVF centers~ ₹ 50 Cr
Borrowing prepayment~ ₹ 20 Cr
Technology & Other Innovation~ ₹ 00 Cr
General Corporate PurposeBalance

Gaudium IVF & Women Health Limited Financial Data

202320242025
Revenue (₹ Cr)₹ 44.2₹ 47.9₹ 70.7
PAT (₹ Cr)₹ 13.5₹ 10.3₹ 19.1
Asset (₹ Cr)₹ 36.6₹ 51.0₹ 88.5
Net Worth (₹ Cr)₹ 22.7₹ 27.0₹ 46.3

Gaudium IVF & Women Health IPO Grey Market Premium

DateIPO PriceIPO GMPProfit per lot
26-Feb₹ 75-79₹0₹0
25-Feb₹ 75-79₹ -4₹ -945
25-Feb₹ 75-79₹ 5₹ 945
24-Feb₹ 75-79₹ 5₹ 945
23-Feb₹ 75-79₹ 8.5₹ 1606.5
22-Feb₹ 75-79₹ 9₹ 1701
21-Feb₹ 75-79₹ 8₹ 1512
20-Feb₹ 75-79₹ 9₹ 1701
19-Feb₹ 75-79₹ 8₹ 1512

Gaudium IVF & Women Health

Gaudium IVF & Women Health Limited IPO Pros & Cons

Strengths:

Risks:

Gaudium IVF & Women Health Limited Promoters – Pre offer equity (Approx)

Dr. Manika Khanna~99.32%
Dr. Peeyush Khanna~0.36%
Vishad Khanna~0.30%

Gaudium IVF & Women Health Limited Lot Size details

Application TypeLot SizeNo. of LotsNo. of SharesInvestment Amt (Max)
Retail(Min)1891189₹ 14,931
Retail (Max)189132457₹ 194,103
Small HNI (Min)189142646₹ 209,034
Small HNI (Max)1896612474₹ 985,446
Big HNI (Min)189671512₹ 1,000,377

Lead Managers / Registrars of Gaudium IVF & Women Health Limited 

Lead / Book Running Lead ManagersSarthi Capital Advisors Private Limited
Registrar (RTA)Bigshare Services Private Limited

Founding Year of Gaudium IVF & Women Health Limited & Managing Director

Gaudium IVF & Women Health Limited was incorporated in the year 2009.

Dr. Manika Khanna is the Founder, Chairperson & Managing Director (MD/CEO) of the company.

Gaudium IVF & Women Health Limited FAQ

  • Last updated on February 27th, 2026 at 08:19 am

    It is a fertility and women’s health services provider operating a hub‑and‑spoke network of assisted reproductive technology clinics across India, offering IVF, ICSI, IUI and related care.

  • Last updated on February 27th, 2026 at 08:19 am

    Gaudium IVF is raising funds via IPO to expand its centre network, set up new IVF clinics, and reduce borrowings.

  • Last updated on February 27th, 2026 at 08:19 am

    The issue size of the IPO is approx ~2.08 crore equity shares. It will be listed on the BSE & NSE platform.

  • Last updated on February 27th, 2026 at 08:19 am

    Key risks include sector regulatory changes, competition, execution challenges in expanding clinics and sensitivity to operational/medical outcomes.

  • Last updated on February 27th, 2026 at 08:19 am

    Upsides include strong growth potential from rising infertility treatment demand in India, expanding patient reach and scaling of pan‑India services.

  • Last updated on February 27th, 2026 at 08:19 am

    You can apply through your broker or bank’s ASBA/UPI facility once the subscription window opens.

  • Last updated on February 27th, 2026 at 08:19 am

    Expected listing date is yet to be announced.

For more amazing blogs click here (IPO Corner).

Leave a comment

RSS
Follow by Email
Pinterest
Instagram
Telegram
WhatsApp